Exercise & CancerNutrition & CancerSurvivorship

Following Exercise and Nutrition Guidelines Can Prolong Life After a Cancer Diagnosis

The American Cancer Society guidelines recommend that survivors engage in physical activity at least 150 minutes a week, and follow diets rich in vegetables, fruits, and whole grains, limiting red and processed meats.
June 2018 Vol 4 No 3
Meg Barbor, MPH

The American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors recommend that survivors engage in regular physical activity and exercise for at least 150 minutes a week, including strength training twice a week.

The guidelines also recommend that survivors should follow diets rich in vegetables, fruits, and whole (instead of refined) grains, and limit their consumption of red and processed meats.

According to Erin Van Blarigan, ScD, Assistant Professor at the University of California, San Francisco, many cancer survivors do not meet these recommendations for diet and exercise because of many barriers, such as side effects, fatigue, conflicting advice from the care team, or the wish to simply “move on” and get back to so-called normal life.

“Emerging data do suggest that people who follow these guidelines have longer survival,” Dr. Van Blarigan said at the 2018 Cancer Survivorship Symposium.

Physical Activity Improves Survival

Research has consistently demonstrated that exercise during and after cancer treatment reduces patients’ symptoms and improves quality of life.

Studies with more than 2,600 women with breast cancer who engaged in exercise during cancer therapy showed that exercise improved the patients’ physical fitness, quality of life, cognitive function, and muscle strength, and reduced their fatigue and mood disturbances, according to Dr. Van Blarigan.

A study of more than 500 women with colon cancer showed that patients who increased their physical activity after a colon cancer diagnosis had half the risk of death compared with patients who did not change their physical activity habits.

Diet and Survival

However, the association between nutrition and survival for patients with cancer or cancer survivors is not so clear, according to Dr. Van Blarigan.

Several studies analyzed 2 diets in patients with cancer—(1) the Prudent diet, which is rich in vegetables, fruits, legumes, fish, poultry, and whole grains, and (2) the Western diet, which includes red meat, processed meat, high-fat dairy, refined grains, snacks, sweets, and desserts.

One study of about 2,000 women with early-stage breast cancer showed that women who consistently followed the Prudent diet (which is rich in vegetables, fruits, fish, and poultry) had a 43% lower risk of death than those who did not follow this diet.

In another study of more than 1,000 patients with stage III colon cancer, those who followed the Western diet (that includes red and processed meat) were more than twice as likely to die than patients who followed a healthier diet.

In addition, many studies suggest that diet after a cancer diagnosis plays a bigger role in terms of cancer recurrence (coming back) and survival; however, it is not easy to separate the effects of individual foods from the overall dietary patterns or other lifestyle factors (such as physical activity or weight) to know what has the greater impact, according to Dr. Van Blarigan.

Nonetheless, a healthy diet can help to reduce the risk for other medical conditions (such as heart disease or diabetes) and potentially prevent cancer progression and recurrence.

To Supplement or Not to Supplement?

The guidelines also recommend that cancer survivors should aim to meet their nutrition needs through a well-balanced diet rather than supplements, but dietary supplements can be used when necessary.

“But it’s important to recognize that many dietary supplements contain levels that exceed amounts found in food or recommended for optimal health, so they should be used carefully,” Dr. Van Blarigan emphasized.

The evidence on taking supplements after a cancer diagnosis suggests it could be beneficial or harmful, depending on whether the person has a deficiency in a particular nutrient.

“The story of vitamin D and colorectal cancer is a promising one,” Dr. Van Blarigan said. In a study called SUNSHINE, patients with metastatic colorectal cancer who took high doses of vitamin D had a longer period without cancer progression than those taking the standard dose of the vitamin. However, Dr. Van Blarigan noted, it is important to remember that vitamin D deficiency is common, especially in New England, where the study was conducted, so those patients might have been deficient in vitamin D and therefore benefited from supplements.

Ask Your Care Team

Remember that dietary supplements during cancer treatment can do harm. For example, in a study of patients with head and neck cancer undergoing radiation therapy, patients who were smokers and took antioxidant supplements during radiation therapy had a 2-fold greater risk of cancer recurrence and death than those who did not take the supplements, but taking the supplements had no effect on patients who were nonsmokers.

“Work with your doctor to determine if you actually need supplementation for an established deficiency or condition,” Dr. Van Blarigan advised.

Join a YMCA Program

The LIVESTRONG Foundation and the YMCA run 12-week group exercise programs, which are offered at many YMCA facilities throughout the country. These programs have been shown to be effective at improving heart health and general quality of life, as well as reducing cancer-related fatigue.

“There is hard evidence to show that participating in these programs can improve outcomes,” Dr. Van Blarigan said.

Digital health interventions that use wearable physical activity trackers, such as the Fitbit, can also help people to become physically active, by providing reminders and motivational messages, strategies, and tips that help people be more active physically.

Patient Resources

American Institute for Cancer Research
National Cancer Institute
Recommended For You
Breast Cancer
Tukysa Improves Survival in Patients with HER2-Positive Breast Cancer that Has Spread to the Brain
By Meg Barbor, MPH
The new cancer drug Tukysa (tucatinib), when given in combination with Herceptin (trastuzumab) and capecitabine, dramatically improved outcomes for patients with HER2-positive advanced breast cancer that has spread to the brain, according to data presented by Nancy U. Lin, MD, Associate Chief, Division of Breast Oncology, Dana-Farber Cancer Institute, Boston, MA, at the 2020 ASCO annual meeting.
Breast Cancer
Adding Kisqali to Endocrine Therapy Increases Survival in Patients with Advanced Breast Cancer and Visceral Metastases
By Meg Barbor, MPH
Metastatic breast cancer is cancer that has spread beyond the breast to other parts of the body. Visceral metastases refer to cancer that has spread to the internal organs of the body, specifically those within the chest (such as the heart or lungs) or abdomen (such as the liver, pancreas, or intestines).
Liver Cancer
Lenvima and Keytruda Combination Shows Promise in Patients with Inoperable Liver Cancer
By Meg Barbor, MPH
The combination of Lenvima (lenvatinib), an oral kinase inhibitor, and the immunotherapy Keytruda (pembrolizumab), a PD-1 inhibitor, showed promising benefits for the treatment of patients with liver cancer (or hepatocellular carcinoma) that cannot be removed by surgery (unresectable).
Lung Cancer
Tecentriq Improves Patient-Reported Outcomes in Advanced Non–Small-Cell Lung Cancer
By Meg Barbor, MPH
Patients with metastatic (spreading to other parts of the body) non–small-cell lung cancer who received the drug Tecentriq (atezolizumab) as a first-line therapy had improvements in physical functioning, without worsening of their lung cancer–related symptoms, compared with patients who received chemotherapy.
Last modified: July 23, 2018

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.